10 min · 10 chaptersNarrated in your voice
What it's about
Sinclair argues that aging is not an inevitable accumulation of damage but a disease caused by loss of epigenetic information, and therefore a treatable condition. Drawing on decades of yeast, mouse, and human research from his Harvard lab, he claims that within our lifetimes medicine could slow, halt, or even reverse aging, radically extending healthy years. The book mattered because it pushed a fringe idea—aging as a drug target—into mainstream science and public policy discussion.
Reading plan
Pick a finish date and Genius lays out the days — the plan shows today's target and keeps you honest.
Read together
Start a circle and share the code — everyone sees everyone's honest place in the book. Accountability, not leaderboards.
Who it's for
- A reader curious about the biology behind longevity supplements and clinics - A scientifically literate adult weighing whether to take metformin, rapamycin, or NMN off-label - A policymaker or investor trying to understand why biotech is pouring money into aging research
What’s inside
- 1Aging Is a Disease, Not a Fact of Life1 min
Classifying aging itself as a treatable disease, rather than an inevitable background process, is the single reframing that justifies the entire research program the book describes.
- 2The Information Theory of Aging1 min
Aging is caused primarily by the loss of epigenetic information that tells cells what type of cell to be, not by accumulated genetic mutations or molecular wear and tear.
- 3The Sirtuin Survival Circuit1 min
A small family of proteins called sirtuins act as an ancient survival circuit that redirects cellular resources from reproduction to repair under stress, and manipulating this circuit can extend lifespan.
- 4Molecules That Mimic Hardship1 min
Compounds like resveratrol, NMN, and metformin can activate the same survival pathways as fasting and exercise, offering a shortcut to their benefits without requiring the actual hardship.
- 5Rapamycin and the mTOR Nutrient-Sensing Pathway1 min
A second, independent longevity pathway centered on the protein mTOR governs how cells respond to nutrient abundance, and drugs that dial it down, like rapamycin, are among the most robust lifespan-extending interventions ever tested in mammals.
- 6Measuring Biological Age1 min
Chronological age is a poor and increasingly obsolete measure of health, and epigenetic clocks that read DNA methylation patterns provide a more accurate, and eventually actionable, gauge of how fast someone is actually aging.
- 7A World Without Aging: Sinclair's Predictions1 min
Within decades, medicine will shift from treating individual age-related diseases to directly slowing or reversing the aging process itself, fundamentally restructuring healthcare, economics, and society.
About David A. Sinclair
David A. Sinclair is a professor of genetics at Harvard Medical School and co-director of the Paul F. Glenn Center for Biology of Aging Research. He co-founded several biotech companies focused on longevity, including Sirtris (acquired by GlaxoSmithKline) and Life Biosciences, and has published extensively on sirtuins, NAD+, and epigenetic reprogramming.
